Summit Therapeutics Inc. SMMT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.39% | -13.87% | 13.57% | 5.44% | 59.03% |
| Total Depreciation and Amortization | 84.78% | 4.55% | 4.76% | 0.00% | 13.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.46% | -4.36% | -36.83% | -16.78% | -72.61% |
| Change in Net Operating Assets | -46.07% | 623.16% | -120.09% | 6.04% | -63.27% |
| Cash from Operations | -13.24% | -15.40% | -19.97% | -9.52% | -39.46% |
| Capital Expenditure | 56.44% | -271.02% | -49.39% | -130.99% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -191.05% | 3,197,114.29% | 100.00% | -- | -100.00% |
| Cash from Investing | -191.60% | 93,753.78% | 99.95% | -683,219.72% | -100.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -58.70% | 5,985.80% | -99.34% | 1,597.04% | 1,421.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -58.70% | 5,985.80% | -99.34% | 1,597.04% | 1,421.74% |
| Foreign Exchange rate Adjustments | -1,000.00% | 105.26% | 0.00% | -186.36% | -63.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.84% | 363.45% | -793.33% | 77.59% | -168.69% |